In the Pipeline

Gastroenterology & Hepatology June 2014, Volume 10, Issue 6 Updates on Promising Agents in Development for Gastroenterology & Hepatology Vedolizumab Approved as Second-line Therapy for Moderate-to-Severe […]

In The Pipeline

Gastroenterology & Hepatology March 2014, Volume 10, Issue 3 Updates on Promising Agents in Development for Gastroenterology & Hepatology Sandhill Scientific Acquired by Medovations Sandhill […]

Updates on Promising Agents in Development for Gastroenterology & Hepatology

Updates on Promising Agents in Development for Gastroenterology & Hepatology FDA Approves Simeprevir for Treatment of Hepatitis C Virus Infection Simeprevir (Janssen), to be marketed as […]